920 related articles for article (PubMed ID: 31844005)
1.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
2. Rezafungin
Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
[TBL] [Abstract][Full Text] [Related]
3. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ibrexafungerp against Candida species isolated from blood cultures. Determination of wild-type populations using the EUCAST method.
Mesquida A; Díaz-García J; Sánchez-Carrillo C; Muñoz P; Escribano P; Guinea J
Clin Microbiol Infect; 2022 Jan; 28(1):140.e1-140.e4. PubMed ID: 34619396
[TBL] [Abstract][Full Text] [Related]
5.
Quindós G; Miranda-Cadena K; San-Millán R; Borroto-Esoda K; Cantón E; Linares-Sicilia MJ; Hamprecht A; Montesinos I; Tortorano AM; Prigitano A; Vidal-García M; Marcos-Arias C; Guridi A; Sanchez-Reus F; Machuca-Bárcena J; Rodríguez-Iglesias MA; Martín-Mazuelos E; Castro-Méndez C; López-Soria L; Ruiz-Gaitán A; Fernandez-Rivero M; Lorenzo D; Capilla J; Rezusta A; Pemán J; Guarro J; Pereira J; Pais C; Romeo O; Ezpeleta G; Jauregizar N; Angulo D; Eraso E
Front Cell Infect Microbiol; 2022; 12():906563. PubMed ID: 35651755
[TBL] [Abstract][Full Text] [Related]
6.
Nunnally NS; Etienne KA; Angulo D; Lockhart SR; Berkow EL
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481447
[TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.
Arendrup MC; Jørgensen KM; Hare RK; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285230
[TBL] [Abstract][Full Text] [Related]
9. Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.
Arendrup MC; Prakash A; Meletiadis J; Sharma C; Chowdhary A
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416539
[No Abstract] [Full Text] [Related]
10. EUCAST Ibrexafungerp MICs and Wild-Type Upper Limits for Contemporary Danish Yeast Isolates.
Jørgensen KM; Astvad KMT; Hare RK; Arendrup MC
J Fungi (Basel); 2022 Oct; 8(10):. PubMed ID: 36294671
[TBL] [Abstract][Full Text] [Related]
11. ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candidaglabrata.
Mesquida A; Díaz-García J; Sánchez-Carrillo C; Martín-Rabadán P; Alcalá L; Muñoz P; Escribano P; Guinea J
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e5-1154.e8. PubMed ID: 35427779
[TBL] [Abstract][Full Text] [Related]
12. Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.
Pfaller MA; Messer SA; Rhomberg PR; Borroto-Esoda K; Castanheira M
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533234
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
14. Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species.
Schell WA; Jones AM; Borroto-Esoda K; Alexander BD
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827419
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ibrexafungerp and comparators against Candida albicans genotypes from vaginal samples and blood cultures.
Mesquida A; Vicente T; Reigadas E; Palomo M; Sánchez-Carrillo C; Muñoz P; Guinea J; Escribano P
Clin Microbiol Infect; 2021 Jun; 27(6):915.e5-915.e8. PubMed ID: 33601007
[TBL] [Abstract][Full Text] [Related]
16.
Aldejohann AM; Menner C; Thielemann N; Martin R; Walther G; Kurzai O
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0132423. PubMed ID: 38206004
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396
[TBL] [Abstract][Full Text] [Related]
18. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
19. Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin.
Arendrup MC; Arikan-Akdagli S; Castanheira M; Guinea J; Locke JB; Meletiadis J; Zaragoza O
J Antimicrob Chemother; 2022 Dec; 78(1):185-195. PubMed ID: 36329639
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data.
Ruiz-Gaitán AC; Cantón E; Fernández-Rivero ME; Ramírez P; Pemán J
Int J Antimicrob Agents; 2019 May; 53(5):541-546. PubMed ID: 30769198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
